Vascular dysfunction produced by hyperhomocysteinemia is more severe in the presence of low folate
Open Access
- 1 January 2006
- journal article
- Published by American Physiological Society in American Journal of Physiology-Heart and Circulatory Physiology
- Vol. 290 (1) , H181-H191
- https://doi.org/10.1152/ajpheart.00765.2005
Abstract
Earlier we reported that dietary folate depletion causes hyperhomocysteinemia (HHcy) and arterial dysfunction in rats (Symons JD, Mullick AE, Ensunsa JL, Ma AA, and Rutledge JC. Arterioscler Thromb Vasc Biol 22: 772–780, 2002). Both HHcy and low folate (LF) are risk factors for cardiovascular disease. Therefore, the dysfunction we observed could have resulted from HHcy, LF, and/or their combination (HHcy + LF). We tested the hypothesis that HHcy-induced vascular dysfunction is more severe in the presence of LF. Four groups of rats consumed diets for ∼10 wk that produced plasma homocysteine (μM) and liver folate (μg folate/g liver) concentrations, respectively, of 7 ± 1 and 15 ± 1 (Control; Con; n = 16), 17 ± 2 and 15 ± 2 (HHcy; n = 17), 10 ± 1 and 8 ± 1 (LF; n = 14), and 21 ± 2 and 8 ± 1 (HHcy + LF; n = 18). We observed that maximal ACh-evoked vasorelaxation was greatest in aortas and mesenteric arteries from Con rats vs. all groups. While the extent of dysfunction was similar between LF and HHcy animals, it was less severe compared with arteries from HHcy + LF rats. Maximal ACh-evoked vasorelaxation in coronary arteries was not different between Con and LF rats, but both were greater than HHcy + LF animals. In segments of aortas, 1) ACh-evoked vasorelaxation was similar among groups after incubation with the nonenzymatic intracellular O scavenger Tiron, 2) vascular O estimated using dihydroethidium staining was greatest in HHcy + LF vs. all groups, and 3) tension development in response to nitric oxide (NO) synthase inhibition was greatest in Con vs. all other groups. We conclude that HHcy + LF evokes greater dysfunction than either HHcy alone (aortas, mesentery) or LF alone (aortas, mesentery, coronary), likely by producing more O within the vasculature and thereby reducing NO bioavailability.Keywords
This publication has 59 references indexed in Scilit:
- Mild hyperhomocysteinemia is a risk-factor in all etiological subtypes of strokeNeurological Sciences, 2004
- Serum Homocysteine in Relation to Mortality and Morbidity From Coronary Heart DiseaseCirculation, 2004
- Endogenous Prostaglandins Limit Angiotensin-II Induced Regional Vasoconstriction in Conscious RatsJournal of Cardiovascular Pharmacology, 2003
- Impaired Nitric Oxide-Mediated Flow-Induced Coronary Dilation in HyperhomocysteinemiaThe American Journal of Pathology, 2002
- Haplotype-Specific Effects on Endothelial NO Synthase Promoter EfficiencyArteriosclerosis, Thrombosis, and Vascular Biology, 2002
- Homocysteine Induces Programmed Cell Death in Human Vascular Endothelial Cells through Activation of the Unfolded Protein ResponseJournal of Biological Chemistry, 2001
- In vitro simultaneous measurements of relaxation and nitric oxide concentration in rat superior mesenteric arteryThe Journal of Physiology, 1999
- HOMOCYSTEINE AND VASCULAR DYSFUNCTIONLife Sciences, 1997
- Impaired endothelial function occurs in the systemic arteries of children with homozygous homocystinuria but not in their heterozygous parentsJournal of the American College of Cardiology, 1993
- Decreased basal nitric oxide release in hypercholesterolemia increases neutrophil adherence to rabbit coronary artery endothelium.Arteriosclerosis and Thrombosis: A Journal of Vascular Biology, 1993